A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
NCT00328432
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
celecoxib 400 mg bid
Sponsor
University of Kansas
Collaborators
[object Object]